Trace amine-associated receptor 1 agonism promotes wakefulness without impairment of cognition in Cynomolgus macaques

Trace Amines and Their Receptors

(2018) Raul R. Gainetdinov et al.   PHARMACOLOGICAL REVIEWS

Deletion of Trace Amine-Associated Receptor 1 Attenuates Behavioral Responses to Caffeine

(2018) Michael D. Schwartz et al.   Frontiers in Pharmacology

Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges

(2017) Mark D. Berry et al.   PHARMACOLOGY & THERAPEUTICS

Trace Amine-Associated Receptor 1 Regulates Wakefulness and EEG Spectral Composition

(2016) Michael D Schwartz et al.   NEUROPSYCHOPHARMACOLOGY

Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys

(2016) Pamela L. Tannenbaum et al.   SLEEP

Inhibition of Orexin Signaling Promotes Sleep Yet Preserves Salient Arousability in Monkeys

(2016) Pamela L. Tannenbaum et al.   SLEEP

Alterations in High-Frequency Neuronal Oscillations in a Cynomolgus Macaque Test of Sustained Attention Following NMDA Receptor Antagonism

(2015) Anushka V Goonawardena et al.   NEUROPSYCHOPHARMACOLOGY

TAAR1 Modulates Cortical Glutamate NMDA Receptor Function

(2015) Stefano Espinoza et al.   NEUROPSYCHOPHARMACOLOGY

Sleep electroencephalographic characteristics of the Cynomolgus monkey measured by telemetry

(2014) Adeline Rachalski et al.   JOURNAL OF SLEEP RESEARCH

Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: Role of D2 dopamine autoreceptors

(2014) D. Leo et al.   NEUROPHARMACOLOGY

Orexin Receptor Antagonists Differ from Standard Sleep Drugs by Promoting Sleep at Doses That Do Not Disrupt Cognition

(2013) J. M. Uslaner et al.   Science Translational Medicine

Trace Amine-Associated Receptor 1 Partial Agonism Reveals Novel Paradigm for Neuropsychiatric Therapeutics

(2012) Florent G. Revel et al.   BIOLOGICAL PSYCHIATRY

A new perspective for schizophrenia: TAAR1 agonists reveal antipsychotic- and antidepressant-like activity, improve cognition and control body weight

(2012) F G Revel et al.   MOLECULAR PSYCHIATRY

Functional Interaction between Trace Amine-Associated Receptor 1 and Dopamine D2 Receptor

(2011) S. Espinoza et al.   MOLECULAR PHARMACOLOGY

TAAR1 activation modulates monoaminergic neurotransmission, preventing hyperdopaminergic and hypoglutamatergic activity

(2011) F. G. Revel et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Ketamine Modulates Theta and Gamma Oscillations

(2009) Maciej T. Lazarewicz et al.   JOURNAL OF COGNITIVE NEUROSCIENCE

How to Keep the Brain Awake? The Complex Molecular Pharmacogenetics of Wake Promotion

(2009) Sibah Hasan et al.   NEUROPSYCHOPHARMACOLOGY

NMDA Receptor Hypofunction Leads to Generalized and Persistent Aberrant γ Oscillations Independent of Hyperlocomotion and the State of Consciousness

(2009) Tahir Hakami et al.   PLoS One

The selective antagonist EPPTB reveals TAAR1-mediated regulatory mechanisms in dopaminergic neurons of the mesolimbic system

(2009) A. Bradaia et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Video-electroencephalography in conscious non human primate using radiotelemetry and computerized analysis: Refinement of a safety pharmacology model

(2009) S. Authier et al.   JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS

A non-invasive technique to monitor wakefulness during electrophysiologic recording experiments in primates

(2008) Olivier Darbin et al.   JOURNAL OF NEUROSCIENCE METHODS

N-methyl-d-aspartic acid receptor antagonist–induced frequency oscillations in mice recreate pattern of electrophysiological deficits in schizophrenia

(2008) R.S. Ehrlichman et al.   NEUROSCIENCE

N-Methyl d-Aspartate Receptor Antagonists Ketamine and MK-801 Induce Wake-Related Aberrant γ Oscillations in the Rat Neocortex

(2007) Didier Pinault   BIOLOGICAL PSYCHIATRY